Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Unknown 5Terminated 4Not yet recruiting 4Completed 4Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 3

Conditions

Urinary Bladder Neoplasms 7Peritoneal Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Colorectal Neoplasms 3Carcinoma, Transitional Cell 3Appendiceal Neoplasms 3Urologic Neoplasms 2Urogenital Neoplasms 2Stomach Neoplasms 2Recurrence 2Pseudomyxoma Peritonei 2Ovarian Neoplasms 2Neoplasms by Site 2Neoplasms 2Anus Neoplasms 2Uterine Neoplasms 1Urologic Diseases 1Urogenital Diseases 1Urinary Bladder Diseases 1Sarcoma 1Pleural Neoplasms 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Necrosis 1Mediastinal Neoplasms 1Male Urogenital Diseases 1Gastrointestinal Neoplasms 1Female Urogenital Diseases 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Bevacizumab 77Fluorouracil 55Cetuximab 48Oxaliplatin 43Leucovorin 42pembrolizumab 37Irinotecan 33Folfox protocol 24Capecitabine 24HMPL-013 22Specimen Handling 19trifluridine tipiracil drug combination 17Panitumumab 15Blood Specimen Collection 15Nivolumab 14Magnetic Resonance Spectroscopy 14regorafenib 13Biopsy 13Trifluridine 12Gemcitabine 12Cisplatin 12Standard of Care 11sintilimab 10Interviews as Topic 10IFL protocol 10Drug Therapy 10Carboplatin 10Cyclophosphamide 9tislelizumab 8Trastuzumab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Colorectal Neoplasms × Mitomycin × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

University of Kentucky

Phase 2 Recruiting
100 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT04329494 2025-12-10

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

City of Hope Medical Center

Phase 1 Recruiting
49 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡